/
MARKET IS OPEN
Loading latest tickers...

Market Indices

S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%

Sector Heatmap

Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%

ADMA — ADMA Biologics, Inc.

Nasdaq

ADMA Biologics, Inc.

Back to Screener
$9.93
-0.10(-1.00%)
O
10.07
H
10.26
L
9.91
V
3.97M
⏱️ End-of-day dataAs of Oct 1, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

ADMA Biologics, Inc. Statistics

Total Valuation

Market Cap$2.10B
Enterprise Value$2.11B

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding223.98M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ratio52.26
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ratio58.41
P/TBV Ration/a
P/FCF Ratio37.75
P/OCF Ratio33.72
PEG Ration/a

Enterprise Valuation

EV / Earnings46.49
EV / Salesn/a
EV / EBITDA39.69
EV / EBIT35.58
EV / FCF37.86

Financial Position

Current Ratio0.70
Quick Ration/a
Debt / Equity0.51
Debt / EBITDA0.38
Debt / FCF0.36
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)116.13%
Return on Assets (ROA)68.14%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$70,059
Employee Count647
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Tax$11.80M
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change-34.02%
50-Day Moving Average$9.38
200-Day Moving Average$11.80
Relative Strength Index (RSI)60.54
Average Volume (20 Days)3,160,058

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profit$80.75M
Operating Income$50.29M
Pretax Income$57.13M
Net Income$45.33M
EBITDA$53.09M
EBIT$59.23M
Earnings Per Share$0.19

Balance Sheet

Cash & Cash Equivalents$13.82M
Total Debt$19.99M
Net Cash-$6.18M
Net Cash Per Share$-0.03
Equity (Book Value)$39.03M
Book Value Per Share$0.17
Working Capital-$22.42M

Cash Flow

Operating Cash Flow$62.30M
Capital Expenditures-$2.54M
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow$55.65M
FCF Per Share$0.25

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yield1.91%
FCF Yield2.65%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Value$2.85
Lynch Upside-71.30%
Graham Number$0.85
Graham Upside-91.44%

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a